Ironwood Pharmaceuticals buy Wells Fargo & Company
Start price
14.12.23
/
50%
€10.20
Target price
14.12.24
€18.27
Performance (%)
-55.88%
Price
06.09.24
€4.10
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Ironwood Pharmaceuticals is performing very badly with a performance of -55.88%. This prediction currently runs until 14.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ironwood Pharmaceuticals | -9.692% | -9.692% |
iShares Core DAX® | -3.429% | 3.133% |
iShares Nasdaq 100 | -6.121% | -1.433% |
iShares Nikkei 225® | -7.364% | 1.018% |
iShares S&P 500 | -4.366% | 0.247% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ironwood Pharmaceuticals diskutieren
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $20.00 price target on the stock.
Ratings data for IRWD provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Start price
Target price
Perf. (%)
€8.40
01.03.24
01.03.24
€12.91
01.03.25
01.03.25
-46.43%
06.09.24
06.09.24